NCT00004409View on ClinicalTrials.gov

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 1995

Study Completion Date

April 30, 2004

Conditions
Dupuytren's Contracture
Interventions
DRUG

collagenase

Trial Locations (2)

94304

Stanford University Hospital, Palo Alto

11790-7775

State University of New York Health Sciences Center - Stony Brook, Stony Brook

All Listed Sponsors
lead

State University of New York

OTHER

NCT00004409 - Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease | Biotech Hunter | Biotech Hunter